New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy

JOHANNESBURG (Reuters) – The new COVID-19 variant identified in South Africa can evade the antibodies that attack it in treatments using blood plasma from previously recovered patients, and may reduce the efficacy of the current line of vaccines, scientists said on Wednesday.

Researchers are racing to establish whether the vaccines currently being rolled out across the globe are effective against the so-called 501Y.V2 variant, identified by South African genomics experts late last year in Nelson Mandela Bay.

“This lineage exhibits complete escape from three classes of therapeutically relevant monoclonal antibodies,” the team of scientists from three South African universities working with the National Institute for Communicable Diseases (NICD) wrote in a paper published in the bioRxiv journal.

“Furthermore, 501Y.V2 shows substantial or complete escape from neutralizing antibodies in COVID-19 convalescent plasma,” they wrote, adding that their conclusions “highlight the prospect of reinfection … and may foreshadow reduced efficacy of current spike-based vaccines.”

The 501Y.V2 variant is 50% more infectious than previous ones, South African researchers said this week. It has already spread to at least 20 countries since being reported to the World Health Organization in late December.

It is one of several new variants discovered in recent months, including others first found in England and Brazil.

The variant is the main driver of South Africa’s second wave of COVID-19 infections, which hit a new daily peak above 21,000 cases earlier this month, far above the first wave, before falling to about 12,000 a day.

Convalescent blood plasma from previous patients has not been shown to be effective when administered to severely ill patients requiring intensive care for COVID-19, but it is approved in several countries as an emergency measure.

British scientists and politicians have expressed concern that vaccines currently being deployed or in development could be less effective against the variant.

The paper said it remained to be seen how effective current vaccines were against 501Y.V2, which would only be determined by large-scale clinical trials. But results showed the need for new vaccines to be designed to tackle the evolving threat, it said.

(Reporting by Tim Cocks; Editing by Peter Graff)

Netherlands proposes first curfew since World War Two, flight bans

By Bart H. Meijer

AMSTERDAM (Reuters) – The Dutch government on Wednesday proposed the first nationwide curfew since World War Two and a ban on flights from South Africa and Britain in its toughest moves yet to limit the spread of coronavirus in the Netherlands.

Prime Minister Mark Rutte said the curfew, which is largely intended to target new, more infectious variants of the disease, must be approved by parliament, which is set to debate measures against the coronavirus on Thursday.

The flight ban, which Rutte said also will apply to all South American countries, will begin on Saturday. The curfew was expected to take effect this weekend, he said.

“This is a very tough measure, but we are at a crossroads,” Rutte said in a televised news conference. “The British variant doesn’t leave us with an alternative.”

The curfew would allow only people with pressing needs to leave their homes between 8:30 p.m. and 4:30 a.m. local time, Rutte said.

Exceptions include medical emergencies, people who need to be outdoors to carry out essential jobs and walking of pets on a leash. Violators can be fined 95 euros ($115).

The government said it will also require all international travelers arriving by airplane or boat to provide proof of a second negative COVID-19 rapid test, taken just before departure. It had already required a negative test taken within 72 hours of travel.

KLM, the Dutch subsidiary of Air France KLM, said that in response to the requirement it will halt 270 weekly long-haul flights and an undetermined number of European flights to the Netherlands from Friday.

“Based on the information we have this will also count for crew members,” said KLM spokeswoman Gerrie Brand. “We cannot take the risk that crew members get stuck abroad, so we have decided to halt all long-haul flights.”

Schools and non-essential shops have already been shut since mid-December, following the closure of bars and restaurants two months earlier. They will remain shut until at least Feb. 9.

Infections in the Netherlands have decreased steadily in the past three weeks, but health authorities say the new variants will lead to a new surge by next month if social distancing measures are not tightened.

The government currently has a caretaker status, as Rutte last Friday handed his resignation to King Willem-Alexander following a damning report on his cabinet’s handling of childcare subsidies.

Rutte has said he will remain to take decisions on COVID-19 policies until a new government is formed after the March 17 elections, seeking broad support for measures from both coalition and opposition parties.

($1 = 0.8264 euros)

(Reporting by Bart Meijer; Additional reporting by Toby Sterling; Writing by Anthony Deutsch; Editing by Giles Elgood, Angus MacSwan, William Maclean)

U.S. exceeds 400,000 coronavirus deaths

By Anurag Maan and Roshan Abraham

(Reuters) – The U.S. coronavirus death toll topped 400,000 on Tuesday, according to a Reuters tally, as the country hardest hit by the pandemic struggled to meet the demand for vaccines to stem the spread of infection.

States including Michigan, New Jersey, New York, Oregon, South Carolina and Vermont have shown signs of vaccine supply strain and are asking for more doses of both approved vaccines, one from Pfizer-BioNTech and the other from Moderna.

The number of deaths has spiked since Christmas.

During the past three weeks, U.S. coronavirus fatalities have totaled 63,793 compared with 52,715 deaths in the three weeks prior to Christmas, an increase of 21%, according to a Reuters analysis.

The daily COVID-19 death numbers crossed 4,000 for the first time on Jan. 6.

Eighteen U.S. states, including California, Pennsylvania, Texas and Washington reported their highest daily death numbers in January, according to the Reuters tally.

The number of coronavirus cases has risen across all U.S. regions and on Tuesday crossed 24 million since the pandemic started.

While seriously ill patients are straining healthcare systems in parts of the country, especially in California, the national rate of hospitalizations has leveled off in the past two weeks and was near 124,000 on Tuesday.

(Reporting by Anurag Maan, Roshan Abraham and Chaithra J in Bengaluru; Editing by Howard Goller)

Spain’s COVID-19 incidence hits new high as third wave of infection rages

MADRID (Reuters) – Spain’s incidence of the coronavirus as measured over the past 14 days reached a new high of 714 cases per 100,000 people on Tuesday after 689 cases the previous day, Health Ministry data showed, as a rampant third wave of infection grips the country.

The ministry reported 34,291 new infections, retreating from Friday’s record rise of more than 40,000, and bringing the cumulative tally to 2,370,742.

Spain’s overall death toll from the virus rose by 404 to 54,173, the data showed. Although daily increases in the death toll have been on the rise, it is still far below the nearly 900 deaths registered per day in late March and early April.

(Reporting by Nathan Allen, editing by Andrei Khalip)

New York governor asks Pfizer to directly sell COVID-19 vaccine doses

By Kanishka Singh

(Reuters) – New York Governor Andrew Cuomo asked Pfizer Inc Chief Executive Albert Bourla on Monday if the state could buy COVID-19 vaccine doses directly from the U.S. drugmaker.

Pfizer, however, told Reuters that such a proposal would first require approval by the U.S. Department of Health and Human Services.

“With hospitalizations and deaths increasing across the country this winter, we are in a footrace with the virus, and we will lose unless we dramatically increase the number of doses getting to New Yorkers,” Cuomo said in a letter to Pfizer’s CEO.

Cuomo said he was appealing to Pfizer directly as the company was “not bound by commitments” that Moderna Inc made as part of Operation Warp Speed, the U.S. government’s program to distribute COVID-19 vaccines.

No state has purchased vaccines directly from the producer. Cuomo’s letter did not state how many doses he was seeking or how he would pay for it.

Pfizer said it was open to collaborating with the U.S. Department of Health and Human Services in a way that would ensure quick vaccine distribution to as many Americans as possible.

(Reporting by Kanishka Singh in Bengaluru; Editing by Howard Goller)

Portugal’s daily COVID deaths hit record high as hospitals struggle

By Catarina Demony and Miguel Pereira

LISBON (Reuters) – Portugal, initially praised for its swift response to the coronavirus pandemic, recorded a record number of COVID-19 related deaths on Monday as its hospitals struggled to cope.

The Portuguese government, facing concerns over low compliance with lockdown measures brought in last week, also introduced further rules to try to curb the spread of the coronavirus among its population of 10 million people.

Portugal posted 167 COVID-19 related deaths over the last 24 hours, bringing the total to 9,028 since the pandemic began.

“After so many cases, and so many deaths, nobody can … think COVID-19 only happens to others,” Portugal’s Prime Minister Antonio Costa told reporters.

Under the new rules, those not able to work remotely will have to carry an employer declaration and people will not be allowed to travel between municipalities over the weekend.

“You see a lot of people not following (the rules) during this new lockdown,” Anabela Ribeiro, 55, said as she left a busy train station in the heart of the capital Lisbon.

“Stricter measures are needed,” Ribeiro added.

Hospitals are struggling to cope with the soaring number of infections, with Portugal now the country with the highest rolling average of new cases over the last seven days per million inhabitants, ourworldindata.org said.

Portugal also reported a record 664 coronavirus patients in intensive care, just below the 672 maximum allocation of ICU beds out of a total of just over 1,000, health authorities said.

With 6,702 new cases the cumulative tally of infections in the country has now reached 556,503.

“The impact is huge because the number of beds doesn’t increase, the walls are not expandable and health workers are not multiplying,” Antonio Pais de Lacerda, a doctor at Lisbon’s biggest hospital, Santa Maria, said.

Portugal has already nearly doubled the number of ICU beds since the start of the pandemic, when it had just 528 critical care beds and Europe’s lowest ratio per 100,000 inhabitants.

(Reporting by Catarina Demony and Miguel Pereira; Additional reporting by Victoria Waldersee and Patricia Vicente Rua; Editing by Andrei Khalip, Timothy Heritage and Alexander Smith)

Mexico aims to make up for Pfizer vaccine shortfall with others

MEXICO CITY (Reuters) – Mexican President Andres Manuel Lopez Obrador said on Monday the government aimed to compensate for a reduction in deliveries of COVID-19 vaccine doses from Pfizer Inc with those from other providers.

The World Health Organization (WHO) said on Monday it was in advanced talks with Pfizer about including its vaccine in the agency’s portfolio of shots to be shared with poorer countries.

Mexico had been expecting weekly deliveries of some 400,000 doses of the Pfizer vaccine developed with Germany’s BioNTech SE. As a result of the U.S. drugmaker’s WHO agreements, Mexico would for now only be receiving half that total, Lopez Obrador told a regular news conference.

It was not clear how long the reduction would last. Pfizer did not immediately reply to a request for comment.

The Pfizer/BioNTech vaccine is currently the only one being administered in Mexico, which has reported the fourth-highest death toll from the pandemic worldwide.

Mexico has also signed deals to acquire vaccines from Britain’s AstraZeneca Plc and China’s CanSino Biologics. Mexico has approved the AstraZeneca shot and expects to have it by March. It is still reviewing the CanSino vaccine.

Lopez Obrador also noted Mexico was about to complete its review of a Russian vaccine, and would soon have it available, an apparent reference to the Sputnik V product.

Mexico suffered a setback to its drive to inoculate the public with the news over the weekend that the official in charge of the program, Miriam Veras Godoy, had stepped down for personal reasons, according to the health ministry.

(Reporting by Raul Cortes; Editing by Bill Berkrot)

Disneyland Paris delays reopening to April 2 due to COVID-19

PARIS (Reuters) – Disneyland Paris said on Monday it was postponing its reopening by almost two months, to April 2, due to the resurgence of the COVID-19 pandemic.

“Due to the prevailing conditions in Europe, Disneyland Paris will not reopen on the 13th of February as initially planned. If conditions permit, we will reopen Disneyland Paris on the 2nd of April, 2021,” the group said on its Twitter account.

France has suffered more than 70,000 deaths from the coronavirus pandemic, among the highest national tolls worldwide, and has begun a mass vaccination program in an effort to ease lockdowns and revive the economy.

On Sunday, the health ministry reported that France had vaccinated more than 422,000 people since the start of the vaccination campaign on Dec. 26.

(Reporting by Richard Lough; Writing by Benoit Van Overstraeten; Editing by Mark Heinrich)

EU kicks off debate on vaccine travel certificates

By Philip Blenkinsop

BRUSSELS (Reuters) – European Union countries kicked off a debate on Monday on whether people who have received a COVID-19 vaccine should have greater freedom to travel in the summer than those not immunized.

Europe ministers from the 27 EU nations held a video conference to discuss greater coordination for the roll-out of vaccines, a topic to be picked up by EU leaders who will meet online on Thursday.

Greek Prime Minister Kyriakos Mitsotakis floated the idea last week in a letter to the European Commission of an EU-wide vaccination certificate to help restore cross-border travel that has been crippled by the pandemic.

German Foreign Minister Heiko Maas said on Sunday that vaccinated people should be able to return sooner to restaurants and cinemas, although other ministers have criticized his view.

Maros Sefcovic, a European Commission vice president, said it was important to stress that vaccination is voluntary – some people were unable or unwilling to receive a vaccine.

Sefcovic told a news conference after Monday’s meeting such people should not have their rights limited. However, vaccination could become a condition for travel, like current requirements in many countries for a negative COVID test.

“There will be different options how we handle travel … the possibility of the electronic vaccination certificate could be added,” he said.

Michael Roth, representing Germany on Monday, said it was vital to establish if vaccinated people could still transmit the coronavirus to others.

The EU executive is working to ensure that vaccination data can be collected electronically in a common form.

The European Centre for Disease Prevention and Control will start collecting data from this week on vaccines delivered and vaccinations per country.

Sefcovic said EU countries needed to be largely synchronized to help keep open its single market, which allows freedom of movement of people and workers.

Many EU nations say they are receiving lower-than-expected supplies of COVID-19 vaccines and complain of uncertainty over future deliveries, EU officials have told Reuters.

(Reporting by Philip Blenkinsop; Editing by Giles Elgood)

Oil slips on coronavirus fears, strong dollar

By Bozorgmehr Sharafedin

LONDON (Reuters) – Oil prices fell slightly on Monday as a stronger dollar, fears over soaring COVID-19 cases around the world and the slow pace of vaccination against the coronavirus outweighed a better-than-expected quarterly rebound for China’s economy.

Brent crude was down 23 cents, or 0.4%, at $54.87 per barrel at 1720 GMT, and West Texas Intermediate U.S. crude fell 19 cents, or 0.4%, to $52.17.

“Corona-induced economic fears, a stronger U.S. dollar and more pessimistic investor sentiment are all playing their part in the fact that Brent is trading … around $3 lower than last Wednesday,” said Commerzbank analyst Eugen Weinberg.

The benchmarks had rallied in the past few weeks, buoyed by COVID-19 vaccine rollouts and a surprise cut in output by Saudi Arabia. But the slow pace of vaccination has raised doubts over how soon economies could recover.

A UK official said Britain’s vaccine rollout was limited by a “lumpy” manufacturing process, and Pfizer Inc said it was distributing fewer doses of its vaccine in Europe in January than originally contracted.

“Vaccination campaigns, although ongoing, are lagging the speed needed to fast-track a global recovery in the first quarter and the comeback for oil demand will be slow,” said Rystad Energy’s head of oil markets Bjornar Tonhaugen.

The U.S. dollar strengthened for a third consecutive day on Monday to a four-week high, weighing on crude prices. Oil is usually priced in dollars, so a stronger dollar makes crude more expensive for buyers with other currencies.

Security concerns ahead of this week’s U.S. presidential inauguration are also dragging on investor sentiment, said PVM Oil analyst Tamas Varga.

“In addition to the coronavirus running amok, this week’s tense presidential inauguration can also cause unease amongst investors,” he said.

Oil prices clawed back some losses after Chinese data showed the economy of the world’s biggest oil importer picked up speed in its recovery from the pandemic.

Prices also found support in a drop in Libyan oil output, with Waha Oil Company reducing production by up to 200,000 barrels per day because of maintenance on the main pipeline that links the Al-Samah and Al-Dhahra oilfields to Es Sider port.

(Reporting by Bozorgmehr Sharafedin in London; Additional reporting by Aaron Sheldrick in Tokyo and Rod Nickel in Winnipeg, Manitoba; Editing by Jason Neely, Mark Potter and Jane Merriman)